Background: Double-beta decay is a rare nuclear process in which two neutrons in the nucleus are converted to two protons with the emission of two electrons and two electron anti-neutrinos. Purpose: We measured the half life of the two-neutrino double-beta decay of 150 Nd to excited final states of 150 Sm by detecting the de-excitation gamma rays of the daughter nucleus. Method: This study yields the first detection of the coincidence gamma rays from the 0 + 1 excited state of 150 Sm. These gamma rays have energies of 333.97 keV and 406.52 keV, and are emitted in coincidence through a 0 + 1 →2 + 1 →0 + gs transition. Results: The enriched Nd2O3 sample consisted of 40.13 g 150 Nd and was observed for 642.8 days at the Kimballton Underground Research Facility, producing 21.6 net events in the region of interest. This count rate gives a half life of T 1/2 = (1.07 +0.45 −0.25 (stat) ± 0.07(syst.)) × 10 20 years. The effective nuclear matrix element was found to be 0.0465 +0.0098 −0.0054. Finally, lower limits were obtained for decays to higher excited final states. Conclusions: Our half-life measurement agrees within uncertainties with another recent measurement in which no coincidence was employed. Our nuclear matrix element calculation may have an impact on a recent neutrinoless double-beta decay nuclear matrix element calculation which implies the decay to the first excited state in 150 Sm is favored over that to the ground state.
Background: Multiple large collaborations are currently searching for neutrinoless double-β decay, with the 5 ultimate goal of differentiating the Majorana-Dirac nature of the neutrino.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.